Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 160 publications
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: July 23, 2026
Quantitative calibration of a spatial QSP model identifies fibroblast impact on HCC immunotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 14, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
Journal: Nature reviews. Clinical oncology
Published: May 06, 2026
Baseline and dynamic cytokines as biomarkers for immune checkpoint and anti-VEGF therapy in advanced hepatocellular carcinoma.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
Journal: Radiology
Published: March 24, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 02, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 19, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.
Journal: Cancer discovery
Published: December 31, 2025
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors.
Journal: Cancer immunology research
Published: December 17, 2025
Last Updated: 09/26/2026